Up-to-date news about Intravacc

Stay informed about the latest developments in our mission to pioneer transformative vaccines with up-to-date corporate communications. Get the latest news on our development and business milestones, as well as industry insights, partnership announcements, and corporate reports.

Category icon
Press releases

Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2

Category icon
Press releases

Intravacc secures $633K funding from CARB-X to develop a vaccine against Neisseria gonorrhoeae.

Category icon
Press releases

Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention

press 1Category icon
Press releases

Intravacc’s inactivated polio vaccine, out licensed to Sinovac, receives market authorization in China

Contact us

You can send us an email:

Reach out to Business Development:

Or pick up the phone: 
+31 30 792 03 00

You can also just fill out the contact form on the right.

We look forward to hearing from you!


Contact form

Subscribe to our newsletter